COVID-19 Impact on Mental Health
Mental Health Prescriptions Spike Amid Pandemic Fears
While recent data published by U.S. Census Bureau and the National Center for Health Statistics shows a drastically heightened prevalence of anxiety and depression in the United States in May 2020, data from Express Scripts, a pharmacy benefit management company, indicates that the coronavirus pandemic started taking a toll on Americans’ mental wellbeing much earlier, right at the onset of the pandemic.
According to data based on an analysis of prescription claims among a sample of 31.5 million commercially insured individuals, prescriptions for anti-anxiety, anti-insomnia and antidepressant medications increased significantly between the week ended February 15 and the week ended March 16.
As the following chart shows, anti-anxiety prescriptions saw the biggest bump at 34.1 percent, while antidepressant and anti-insomnia medication was up 18.6 percent and 14.8 percent, respectively. The WHO officially declared the coronavirus outbreak a pandemic on March 11, coinciding with the sample week the growth rates are based on.
Description
This chart shows the increase in weekly prescriptions for anti-anxiety, anti-insomnia and antidepressant medications in the U.S. between the week ended March 11 and the week ended February 15.
Related Infographics
Any more questions?
Get in touch with us quickly and easily.
We are happy to help!
Statista Content & Design
Need infographics, animated videos, presentations, data research or social media charts?